Professor Ewan Pearson
Chair of Diabetic Medicine
Diabetes Endocrinology and Reproductive Biology, School of Medicine
Contact
Biography
Ewan Pearson is Professor of Diabetic Medicine at the University of Dundee and Honorary Consultant in Diabetes and Endocrinology at Ninewells Hospital and Medical School in Dundee. Ewan is an Associate Director for the British Heart Foundation Data Science Centre, where he leads the Diabetes Data Catalyst.
Ewan obtained his medical degree from the University of Cambridge School of Clinical Medicine, UK. He undertook a Wellcome Trust Clinical Training fellowship with Prof Andrew Hattersley at the University of Exeter Medical School, UK and completed his PhD in the physiology and treatment of monogenic diabetes. He then moved to Dundee where he was supported by a Chief Scientist Office Clinician Scientist fellowship and then by a Wellcome Trust Investigator Award. Over the last fifteen years in Dundee his research interests have been in the phenotypic and genotypic determinants of drug response in diabetes, and in stratified approaches to the management of diabetes. He lead the IMI-DIRECT project on stratification in type 2 diabetes and was WP lead for the IMI-SOPHIA project on obesity outcomes. Ewan also leads the recently awarded £2.8M iDiabetes programme - to implement precision diabetes care in Tayside. Ewan was chair of the Wellcome Clinical interviews committee and then co-chair of the Wellcome Early Career Awards Committee.
Ewan has been awarded the Royal College of Physicians of Edinburgh Croom Lecture, an EASD Rising Star award, the Diabetes UK RD Lawrence Lecture, the EASD Minkowski Award, the Diabetes UK Dorothy Hodgkin Lecture and Society for Endocrinology Medal for his work in these areas. In 2022 Ewan was elected as a Fellow of the Royal Society of Edinburgh.
Media availability
I am available for media commentary on my research.
Professor Pearson is a clinical academic diabetologist whose research includes discovery and implementation of precision medicine approaches to the management of diabetes and obesity, and pharmacogenetics of commonly used drugs. Areas of expertise include monogenic diabetes, human physiology, precision medicine trials, population genomics and pharmacogenomics.
Contact Corporate Communications for media enquiries.
Areas of expertise
- Diabetes
Stories
Press release
The effectiveness of some common type 2 diabetes medications may depend upon an individual’s genetic make-up, a University of Dundee study has found.
Press release
A major new study is allowing people living with type 2 diabetes to choose their medication.
Press release
A University of Dundee expert will help spearhead a major research initiative to untangle the link between diabetes and heart disease - two of the biggest health crises in Scotland.